Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A.C.T. Holdings, Inc. Announces Name Change to Advanced Cell Technology, Inc.; Company Receives New Trading Symbol: OTCBB: ACTC.


WORCESTER, Mass. -- A.C.T. Holdings, Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:ACTH ACTH: see adrenocorticotropic hormone.
ACTH
 in full adrenocorticotropic hormone

Polypeptide hormone made in the pituitary gland.
) today announced a company name change from A.C.T. Holdings, Inc. to Advanced Cell Technology, Inc. In connection with the name change, the company's trading symbol Trading symbol

See: Ticker symbol
 has been changed from ACTH to ACTC ACTC Apple Certified Technical Coordinator
ACTC Almaden Cycle Touring Club
ACTC Associated Colleges of the Twin Cities
ACTC All Ceylon Tamil Congress (Sri Lanka)
ACTC Association Canadienne de Télévision par Câble
. These changes will become effective beginning on June 23, 2005.

"Our company has undergone significant changes in the past year and this name change represents those developments," said William Caldwell, Chief Executive Officer of Advanced Cell Technology, Inc. "Now a publicly traded company publicly traded company

A company whose shares of common stock are held by the public and are available for purchase by investors. The shares of publicly traded firms are bought and sold on the organized exchanges or in the over-the-counter market.
, we have expanded our scientific and research teams to include some of the world's leading scientists in the field of stem cell stem cell

In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult.
 research and development, built a distinguished senior management team, further developed our intellectual property portfolio which now represents one of the strongest in the field, and continued to focus on developing and commercializing human stem cell technology in the emerging field of regenerative re·gen·er·a·tive  
adj.
1. Of, relating to, or marked by regeneration.

2. Tending to regenerate.



re·gen
 medicine."

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc., a Nevada corporation A Nevada Corporation is a corporation chartered under the laws of the U.S. state of Nevada.

Nevada, like the state of Delaware (See Delaware corporation), is well known as a corporate haven.
, is a biotechnology company applying stem cell technology in the emerging field of regenerative medicine. The company is currently headquartered in Worcester, Massachusetts.

For more information about the company visit http://www.advancedcell.com.

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and its subsidiary, Advanced Cell, Inc., and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended March 31, 2005.

Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 22, 2005
Words:428
Previous Article:Fitch Ratings Issues Presale Report on Acacia CDO 8, Ltd.
Next Article:Schaeffer's S&P 500 Index Hot Stocks Features Jabil Circuit, E*TRADE Financial, Visteon, Albertson's, and Reebok International.
Topics:



Related Articles
Dr. Robert Lanza of Advanced Cell Technology to Testify before Senate Subcommittee; Testimony to Address Alternative Methods for Obtaining Embryonic...
Robert Lanza, M.D. to Deliver a Keynote Presentation at the Biotechniques Live! / Drug Discovery Technology & Development World Congress' Annual...
Advanced Cell Technology to Deliver the Keynote Address at the Strategies for Engineered Negligible Senescence (SENS) Conference.
Advanced Cell Technology Raises $17.75 Million through Private Placement of Convertible Notes and Warrants.
Executive Team of Advanced Cell Technology, Inc. to Present at the PIPEs Conference 2005 in New York.
Advanced Cell Technology to Participate in the BIO CEO & Investor Conference 2006.
Dr. Robert Lanza Receives 2006 'All Star' Award for Biotechnology.
Investor's Business Daily Cites Advanced Cell Technology's Scientific Leadership in Burgeoning Embryonic Stem Cell Industry.
Advanced Cell Technology Releases Corporate Video Presentation Highlighting Company's Pioneering Stem Cell Science and Therapeutic Development...
Advanced Cell Technology Acquires Intellectual Property Assets of Infigen, Inc.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles